Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 01, 2022 08:22 ET | Source: Cornerstone Capital Resources Inc.

Brama–Alba porphyry system at Bramaderos Project in Ecuador now 1.1km long, 400m wide and open

OTTAWA, June 01, 2022 (GLOBE NEWSWIRE) -- Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV:CGP; OTC:CTNXF; FWB:GWN1) is pleased to provide an update on its Bramaderos gold...
June 01, 2022 08:00 ET | Source: CinCor Pharma, Inc.

CinCor Pharma Doses First Patient in Phase 2 FigHTN-CKD Trial Evaluating the Selective Aldosterone Synthase Inhibitor Baxdrostat (CIN-107) in Patients with Uncontrolled Hypertension and Chronic Kidney Disease

figHTN-CKD is CinCor’s fourth ongoing Phase 2 clinical trial evaluating baxdrostat (CIN-107) Initial topline data for figHTN-CKD expected in 2H 2023 WALTHAM, Mass., June 01, 2022 (GLOBE NEWSWIRE)...
May 31, 2022 16:05 ET | Source: CinCor Pharma Inc

CinCor Pharma to Present at the Jefferies Healthcare Conference

WALTHAM, Mass., May 31, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced participation at the Jefferies 2022 Healthcare Conference taking place June 8 - 10 in New York,...
May 24, 2022 13:08 ET | Source: Patriot Battery Metals

Patriot Drills 70.1 m of 2.22% Li2O including an interval 40.7 m of 3.01% Li2O in First Drill Hole to Test the CV1 Pegmatite at the East End of the Winter Drilling Corridor at the Corvette Property, Quebec

Highlights Strongest lithium grades to date returned from drilling at the Property in first hole (CV22-017) to test the CV1 Pegmatite 3.01% Li2O and 160 ppm Ta2O5 over 40.7 m within a wider zone...
May 17, 2022 16:05 ET | Source: CinCor Pharma Inc

CinCor Pharma to Present at Upcoming Investor Conferences

WALTHAM, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that management will present at the H.C. Wainwright 2022 Global Investment Conference taking place...
May 17, 2022 08:00 ET | Source: Patriot Battery Metals

Patriot Drills 1.17% Li2O over 33.8 m and 0.85% Li2O over 56.6 m, Extending Mineralization along Trend and Down-dip in First Reported Core Assays from 2022 Drilling at the Corvette Property, Quebec

Highlights Strong lithium and tantalum mineralization confirmed in first series of core sample assays received for drill holes CV22-015, 016, 018, and 019, including 1.17% Li2O and 111 ppm Ta2O5 over...
May 10, 2022 08:00 ET | Source: CinCor Pharma Inc

CinCor Reports First Quarter Financial Results and Provides Corporate Update

Topline data for baxdrostat (CIN-107) in BrigHtn Phase 2 trial for treatment-resistant hypertension (rHTN) expected in 2H 2022 Topline data for baxdrostat (CIN-107) in HALO Phase 2 trial for...
May 09, 2022 16:05 ET | Source: Caribou Biosciences, Inc.

Caribou Biosciences Reports First Quarter 2022 Financial Results and Provides Business Updates

-- Initial ANTLER Phase 1 clinical data scheduled to be shared at the European Hematology Association (EHA) 2022 Hybrid Congress for CB-010, the Company’s lead allogeneic cell therapy candidate, in...
May 05, 2022 08:30 ET | Source: Sun Country Airlines

Sun Country Airlines Reports First Quarter 2022 Results

Q1 2022 GAAP diluted EPS of $0.06 and operating income of $22 millionQ1 2022 Adjusted diluted EPS of $0.20(1) and adjusted operating income of $23 million(1) MINNEAPOLIS, May 05, 2022 (GLOBE...
May 04, 2022 16:02 ET | Source: Allogene Therapeutics, Inc.

Allogene Therapeutics Reports First Quarter 2022 Financial Results

Pivotal Phase 2 ALPHA2 Trial of ALLO-501A in R/R Large B Cell Lymphoma Planned to Commence Mid 2022 Using Product from Cell Forge 1 (CF1) CF1 is Projected to Support the Manufacture of ~20,000 Doses...